PUBLICATION
Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene
- Authors
- Wang, X., Xu, X., Jiang, G., Zhang, C., Liu, L., Kang, J., Wang, J., Owusu, L., Zhou, L., Zhang, L., Li, W.
- ID
- ZDB-PUB-210507-22
- Date
- 2020
- Source
- Journal of Cellular and Molecular Medicine 24: 11177-11187 (Journal)
- Registered Authors
- Keywords
- PIK3CA, dihydrotanshinone I, migration, ovarian cancer, proliferation
- MeSH Terms
-
- Quinones/chemistry
- Quinones/pharmacology*
- Quinones/therapeutic use
- Cell Death/drug effects
- Female
- Class I Phosphatidylinositol 3-Kinases/genetics*
- Class I Phosphatidylinositol 3-Kinases/metabolism
- Carcinoma, Ovarian Epithelial/enzymology
- Carcinoma, Ovarian Epithelial/genetics
- Carcinoma, Ovarian Epithelial/pathology
- Gene Expression Profiling
- Cell Line, Tumor
- Phosphatidylinositol 3-Kinases/metabolism
- Neoplasm Metastasis
- Phenanthrenes/chemistry
- Phenanthrenes/pharmacology*
- Phenanthrenes/therapeutic use
- Gene Expression Regulation, Neoplastic/drug effects
- Proto-Oncogene Proteins c-akt/metabolism
- Animals
- Drug Resistance, Neoplasm/drug effects
- Drug Resistance, Neoplasm/genetics
- Disease Models, Animal
- Platinum/pharmacology
- Platinum/therapeutic use
- Cell Movement*/drug effects
- Cell Movement*/genetics
- Furans/chemistry
- Furans/pharmacology*
- Furans/therapeutic use
- Zebrafish
- Humans
- Neoplasm Invasiveness
- Ovarian Neoplasms/drug therapy
- Ovarian Neoplasms/enzymology
- Ovarian Neoplasms/genetics*
- Ovarian Neoplasms/pathology*
- Transcription, Genetic*/drug effects
- Cell Proliferation/drug effects
- Signal Transduction/drug effects
- PubMed
- 32860347 Full text @ J. Cell. Mol. Med.
Citation
Wang, X., Xu, X., Jiang, G., Zhang, C., Liu, L., Kang, J., Wang, J., Owusu, L., Zhou, L., Zhang, L., Li, W. (2020) Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene. Journal of Cellular and Molecular Medicine. 24:11177-11187.
Abstract
Dihydrotanshinone I (DHTS), extracted from Salvia miltiorrhiza, was found to be the most effective compound of tanshen extracts against cancer cells in our previous studies. However, the therapeutic benefits and underlying mechanisms of DHTS on ovarian cancer remain uncertain. In this study, we demonstrated the cytocidal effects of DHTS on chemosensitive ovarian cancer cells with or without platinum-based chemotherapy. DHTS was able to inhibit proliferation and migration of ovarian cancer cells in vitro and in vivo through modulation of the PI3K/AKT signalling pathways. Combinatorial treatment of DHTS and cisplatin exhibited enhanced DNA damage in ovarian cancer cells. Overall, these findings suggest that DHTS induces ovarian cancer cells death via induction of DNA damage and inhibits ovarian cancer cell proliferation and migration.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping